Venous Thromboembolism and Chronic Pain After Major Limb Trauma
THROMBO-PAIN
2 other identifiers
observational
150
1 country
1
Brief Summary
Major limb trauma is associated with a high risk of venous thromboembolism (VTE) due to systemic inflammation, endothelial injury, immobilization, and hypercoagulability. While VTE is commonly studied as a short-term complication affecting morbidity and mortality, its potential relationship with long-term pain outcomes after trauma has not been well investigated. This prospective observational cohort study aims to evaluate whether objectively confirmed VTE is associated with an increased risk of persistent clinically significant pain after major limb trauma. Adult patients with severe upper or lower limb injuries requiring surgical treatment or prolonged immobilization will be enrolled within 72 hours of hospital admission and followed for six months. The study will assess whether patients who develop VTE have a higher likelihood of persistent pain compared with those without VTE. In addition, the study will explore the association between baseline VTE risk (using the Trauma Embolic Scoring System, TESS), thromboprophylaxis timing, and long-term pain outcomes. Secondary analyses will evaluate neuropathic pain symptoms, pain interference with daily activities, quality of life, opioid consumption, and functional recovery. Understanding the relationship between thromboembolic complications and persistent pain may help improve risk stratification, optimize thromboprophylaxis strategies, and support early rehabilitation planning in patients with major limb trauma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedMarch 18, 2026
March 1, 2026
Same day
March 13, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Persistent Clinically Significant Pain After Major Limb Trauma
Persistent pain defined as Numeric Rating Scale (NRS) ≥4 during movement or functional activity at 3 or 6 months after injury. Pain intensity will be assessed using the standardized 0-10 Numeric Rating Scale during follow-up evaluations.
3 months and 6 months after injury
Secondary Outcomes (2)
Neuropathic Pain
6 weeks, 3 months, and 6 months after injury.
Opioid Consumption
Time Frame: up to 6 months after injury.
Study Arms (1)
Major Limb Trauma Cohort
Adult patients with major upper or lower limb trauma requiring surgical treatment and/or prolonged immobilization (≥72 hours). Participants will be enrolled within 72 hours of admission and followed prospectively for 6 months to evaluate the association between venous thromboembolism (VTE) and persistent post-traumatic pain. VTE events will be identified during hospitalization or within 30 days after injury using standard diagnostic imaging.
Eligibility Criteria
The study population will include adult patients (≥18 years) with major upper or lower limb trauma requiring surgical treatment and/or prolonged immobilization (≥72 hours). Participants will be recruited from trauma centers managing severe civilian and combat-related injuries. Eligible patients will be enrolled within 72 hours of hospital admission. The cohort will include patients with various mechanisms of injury, including blast injuries, fragmentation injuries, gunshot wounds, and other high-energy trauma. Participants will be followed prospectively for up to 6 months to evaluate the association between venous thromboembolism (VTE) and the development of persistent post-traumatic pain.
You may qualify if:
- Age ≥18 years
- Major upper or lower limb trauma
- Surgical treatment and/or immobilization ≥72 hours
- Enrollment within 72 hours of admission
- Informed consent
You may not qualify if:
- Pre-existing chronic pain unrelated to trauma (investigator judgment)
- Therapeutic anticoagulation prior to trauma
- Cognitive inability to complete follow-up
- Expected survival \<48 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Superhumans War Trauma Center
Lviv, Ukraine
Related Publications (1)
Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004 Sep;240(3):490-6; discussion 496-8. doi: 10.1097/01.sla.0000137138.40116.6c.
PMID: 15319720RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of science department, PhD, Professor
Study Record Dates
First Submitted
March 13, 2026
First Posted
March 17, 2026
Study Start
March 15, 2026
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to ethical, legal, and privacy considerations related to sensitive clinical data from trauma patients, including individuals with combat-related injuries. The dataset may contain potentially identifiable health information and operational details. De-identified aggregated data may be made available upon reasonable request to the study investigators and subject to approval by the institutional ethics committee and applicable data protection regulations.